Skip to main content
Theraclion SA logo

Theraclion SA — Investor Relations & Filings

Ticker · ALTHE ISIN · FR0010120402 LEI · 9695007X7HA7A1GCYD29 PA Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2022-02-25 Capital/Financing Update
Country FR France
Listing PA ALTHE

About Theraclion SA

https://www.theraclion.com/?_ga=2.14878…

Theraclion SA is a medical device company specializing in the development and marketing of non-invasive therapeutic solutions using High-Intensity Focused Ultrasound (HIFU). The company's technology, known as echotherapy, provides a non-surgical alternative for tissue ablation. Its flagship product, SONOVEIN®, is a robotic solution for the non-invasive treatment of varicose veins. The system uses external ultrasound beams to ablate the target vein without incisions, catheters, or sedation, allowing for immediate patient recovery. Theraclion also developed ECHOPULSE®, a system for the treatment of thyroid nodules and breast fibroadenomas. The company's core focus is on providing precise, non-invasive treatments that reduce risks and recovery time compared to traditional surgical procedures.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Capital/Financing Update Classification · 99% confidence The document is a press release titled "Theraclion annonce le vif succès d'une augmentation de capital de 6,5 millions d'euros" (Theraclion announces the great success of a capital increase of 6.5 million euros). The text details the issuance of new ordinary shares, the subscription process, the price, and the resulting change in shareholder structure. This content directly relates to fundraising, financing activities, and capital structure changes. Based on the definitions: - It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). - It explicitly discusses an 'augmentation de capital' (capital increase) and 'levée de fonds' (fundraising). - This aligns perfectly with the definition for Capital/Financing Update (Code: CAP). - It is not a general regulatory announcement (RNS) because it describes a specific corporate financing event in detail, nor is it a Report Publication Announcement (RPA) as it is the primary announcement of the event itself, not just a notice that a report is available.
2022-02-25 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated February 9, 2022, from Theraclion, detailing the company's strategy across three therapeutic areas (varicose veins, thyroid, breast cancer) and providing updates on product adoption (SONOVEIN®, ECHOPULSE®) and clinical collaborations (UVA). It discusses business strategy, market focus, and clinical progress, but it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a comprehensive interim report (IR). It reads like an update intended for investors and the market regarding strategic direction and recent developments, which aligns best with an Investor Presentation (IP) or a general corporate update. Given the strategic focus and lack of specific financial tables typical of an ER or IR, 'Investor Presentation' (IP) is the most fitting category for this type of strategic communication, although it is presented as a press release. Since 'Investor Presentation' covers detailed information for investors on strategy and market position, this fits well. It is short and not a formal regulatory filing announcement, so RPA/RNS is less appropriate than classifying the content type itself.
2022-02-09 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
AGM Information Classification · 99% confidence The document is titled "Compte-rendu de l'assemblée générale ordinaire de Theraclion" (Minutes of the Ordinary General Meeting of Theraclion) and explicitly states that the general meeting of shareholders was held on January 28, 2022. It details the resolutions adopted, specifically the appointment and ratification of board members (Cédric Bellanger and Yann Duchesne). This content directly relates to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length (4144 chars) is substantial enough to be the report itself, not just an announcement of publication.
2022-02-07 French
Inside Information / Information on annual revenues
Earnings Release Classification · 95% confidence The document is dated January 31, 2022, and provides a review of strategic achievements in 2021, including revenue figures for 2021 compared to 2020, and outlines the plan for 2022. It discusses business developments, technological pivots (AI), market expansion (Italy, Serbia, US FDA trial), and governance changes (new Executive Chairman). This content structure—reviewing the past year's performance and setting future strategy—is characteristic of an Annual Report (10-K) or a preliminary Earnings Release (ER) that often precedes the full 10-K filing. However, the text is a narrative update focusing on strategic milestones and key financial highlights (turnover doubling) rather than a comprehensive, legally mandated financial statement typical of a full 10-K. It is too detailed for a simple Earnings Release (ER) which usually focuses only on the headline numbers. It also mentions governance changes, which could suggest DEF 14A content, but the primary focus is operational and financial review. Given the comprehensive nature of the review of the past year's performance and the forward-looking strategy, it most closely resembles the content found in an Annual Report (10-K) or a detailed Management Discussion & Analysis (MDA) section thereof. Since it is a narrative summary of the year's performance and outlook, and not explicitly stated as an announcement of a report, 'MDA' (Management's detailed explanation of financial results, business trends, and outlook) is a strong fit, as is 'ER' if it's the primary release. Comparing the options, the detailed strategic review and financial table strongly suggest it is either the core of an Earnings Release or a Management Report. Since it is a detailed narrative review of the year's performance and strategy, 'MDA' is the most appropriate classification for this type of content, which often accompanies or precedes the formal 10-K filing. FY 2022
2022-01-31 English
Informations privilégiées / Information sur chiffre d’affaires annuel
Earnings Release Classification · 95% confidence The document is dated January 31, 2022, and provides a review of strategic achievements in 2021, financial highlights (revenue table for 2021 vs 2020), technological updates (AI integration for SONOVEIN®), market expansion details (Italy, Serbia, US FDA trial), and governance changes (new Chairman). It summarizes performance for a completed period (2021) and outlines future strategy. This content structure strongly suggests an annual or periodic performance review, but it is not the full, audited 10-K. It reads like a press release summarizing the year's performance and outlook, which aligns best with an Earnings Release (ER) or potentially a Management Discussion & Analysis (MDA) if it were more detailed. Given the format (press release style, key figures, strategic narrative) and the timing (early in the year, summarizing the previous year), it functions as the initial announcement of the annual performance summary. Since it contains specific financial figures and a review of the past year's operations, 'ER' (Earnings Release) is the most appropriate classification for this type of summary announcement, even though it covers the full year rather than a quarter. It is not a full 10-K, nor is it a presentation (IP) or a formal audit report (AR). FY 2022
2022-01-31 French
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 99% confidence The document announces the appointment of Yann Duchesne as Chairman of the Board following the death of the previous chairman. It details his background and outlines the future strategic direction under his leadership. This content directly relates to changes in the company's senior leadership and board structure. This aligns perfectly with the definition of 'Board/Management Information' (Code: MANG). The document is a press release format, not a formal regulatory filing like a 10-K or an earnings release (ER).
2022-01-24 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.